What is the current stock price of Comera Life Sciences Holdings, Inc. (CMRA)?

As of the latest market data, Comera Life Sciences Holdings, Inc. (CMRA) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Comera Life Sciences Holdings, Inc. (CMRA) pay a dividend?

Based on current data, Comera Life Sciences Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of Comera Life Sciences Holdings, Inc.?

The current market capitalization of Comera Life Sciences Holdings, Inc. (CMRA) is approximately unavailable.

CMRA

Comera Life Sciences Holdings, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

CMRA NEWS

defenseworld.net

Mar 5

Actinium Pharmaceuticals (NYSE:ATNM) vs. Comera Life Sciences (NASDAQ:CMRA) Critical Comparison

Actinium Pharmaceuticals (NYSE: ATNM - Get Free Report) and Comera Life Sciences (NASDAQ: CMRA - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Valuation and Earnings This table compares

Company Profile

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2020-12-21

Beta

-20.43

Websitecomeralifesciences.com↗